| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA Helicases | 2 | 2022 | 101 | 1.530 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 3 | 2018 | 182 | 1.520 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 3 | 2023 | 425 | 1.330 |
Why?
|
| Receptors, Androgen | 4 | 2023 | 878 | 1.150 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2023 | 2054 | 1.120 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2018 | 221 | 1.060 |
Why?
|
| Prostatic Neoplasms | 9 | 2022 | 5767 | 1.030 |
Why?
|
| Inflammation | 5 | 2022 | 2522 | 0.980 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2023 | 41 | 0.930 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2023 | 639 | 0.930 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2022 | 16 | 0.880 |
Why?
|
| Guanidines | 1 | 2022 | 60 | 0.870 |
Why?
|
| Keto Acids | 1 | 2022 | 59 | 0.870 |
Why?
|
| Prostate | 6 | 2014 | 1088 | 0.860 |
Why?
|
| GATA2 Transcription Factor | 1 | 2022 | 68 | 0.850 |
Why?
|
| Transaminases | 1 | 2022 | 76 | 0.850 |
Why?
|
| Co-Repressor Proteins | 1 | 2021 | 122 | 0.790 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 170 | 0.760 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 558 | 0.730 |
Why?
|
| Stromal Cells | 5 | 2014 | 825 | 0.700 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2023 | 1678 | 0.660 |
Why?
|
| Alpharetrovirus | 1 | 2018 | 7 | 0.650 |
Why?
|
| Gene Transfer Techniques | 2 | 2018 | 716 | 0.620 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 854 | 0.600 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 276 | 0.580 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 848 | 0.580 |
Why?
|
| Retroviridae | 1 | 2017 | 332 | 0.570 |
Why?
|
| Transforming Growth Factor beta | 3 | 2014 | 1130 | 0.550 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2014 | 229 | 0.520 |
Why?
|
| Neoplasms | 5 | 2023 | 15193 | 0.480 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2023 | 8873 | 0.410 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 1215 | 0.410 |
Why?
|
| Mice | 17 | 2022 | 34495 | 0.410 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 3869 | 0.350 |
Why?
|
| Animals | 20 | 2022 | 59536 | 0.340 |
Why?
|
| Cell Line, Tumor | 9 | 2023 | 14551 | 0.330 |
Why?
|
| Androgens | 3 | 2023 | 511 | 0.320 |
Why?
|
| Mice, SCID | 2 | 2022 | 1869 | 0.300 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2007 | 223 | 0.290 |
Why?
|
| Immediate-Early Proteins | 1 | 2005 | 107 | 0.260 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2022 | 986 | 0.240 |
Why?
|
| Signal Transduction | 5 | 2023 | 11965 | 0.240 |
Why?
|
| Proteins | 4 | 2014 | 1963 | 0.230 |
Why?
|
| Androgen Antagonists | 2 | 2023 | 411 | 0.230 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2017 | 2359 | 0.220 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2022 | 22 | 0.220 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 650 | 0.210 |
Why?
|
| Micrococcal Nuclease | 1 | 2001 | 10 | 0.210 |
Why?
|
| Staphylococcus | 1 | 2001 | 86 | 0.200 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2021 | 280 | 0.190 |
Why?
|
| Kupffer Cells | 1 | 2020 | 42 | 0.180 |
Why?
|
| Protein Isoforms | 1 | 2022 | 842 | 0.180 |
Why?
|
| Th1 Cells | 1 | 2021 | 250 | 0.180 |
Why?
|
| Th17 Cells | 1 | 2021 | 162 | 0.180 |
Why?
|
| Mice, Knockout | 3 | 2021 | 5710 | 0.170 |
Why?
|
| Protein Conformation | 3 | 2003 | 1258 | 0.170 |
Why?
|
| Hepatitis | 1 | 2020 | 93 | 0.170 |
Why?
|
| Receptors, Calcitriol | 1 | 2020 | 134 | 0.170 |
Why?
|
| Mass Spectrometry | 1 | 2001 | 702 | 0.170 |
Why?
|
| Cell Line | 4 | 2021 | 5114 | 0.160 |
Why?
|
| Serine Endopeptidases | 2 | 2014 | 275 | 0.160 |
Why?
|
| Humans | 20 | 2023 | 261506 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 6942 | 0.150 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 987 | 0.150 |
Why?
|
| Ribosomes | 1 | 1997 | 147 | 0.150 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 15694 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 1538 | 0.140 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 673 | 0.140 |
Why?
|
| HEK293 Cells | 1 | 2021 | 1489 | 0.140 |
Why?
|
| Luciferases | 1 | 1997 | 445 | 0.140 |
Why?
|
| Cell Survival | 1 | 2022 | 3045 | 0.140 |
Why?
|
| Calcium | 1 | 2022 | 1537 | 0.140 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 992 | 0.140 |
Why?
|
| Cysteine Endopeptidases | 1 | 2017 | 251 | 0.140 |
Why?
|
| Endopeptidases | 1 | 2017 | 220 | 0.130 |
Why?
|
| Carcinoma | 1 | 2007 | 2578 | 0.130 |
Why?
|
| Transplantation, Heterologous | 3 | 2007 | 1082 | 0.130 |
Why?
|
| Male | 14 | 2023 | 123000 | 0.130 |
Why?
|
| Mitochondria | 1 | 2022 | 1282 | 0.130 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2014 | 13 | 0.130 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 7222 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 1546 | 0.130 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 5112 | 0.130 |
Why?
|
| Pteridines | 1 | 2014 | 34 | 0.130 |
Why?
|
| Transforming Growth Factor beta1 | 3 | 2014 | 292 | 0.130 |
Why?
|
| Kallikreins | 1 | 2014 | 84 | 0.120 |
Why?
|
| Oncogenes | 1 | 2018 | 673 | 0.120 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 421 | 0.120 |
Why?
|
| Phenylthiohydantoin | 1 | 2014 | 89 | 0.120 |
Why?
|
| Insulin Resistance | 1 | 2020 | 731 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 2 | 2014 | 5395 | 0.120 |
Why?
|
| Sequence Deletion | 1 | 2017 | 875 | 0.120 |
Why?
|
| DNA Repair | 1 | 2021 | 1872 | 0.120 |
Why?
|
| Myofibroblasts | 1 | 2014 | 133 | 0.120 |
Why?
|
| Microarray Analysis | 1 | 2014 | 392 | 0.120 |
Why?
|
| DNA Damage | 1 | 2021 | 1954 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2022 | 3821 | 0.110 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2014 | 217 | 0.110 |
Why?
|
| Mice, Nude | 4 | 2014 | 4307 | 0.110 |
Why?
|
| Mice, Inbred ICR | 1 | 2013 | 239 | 0.110 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 4143 | 0.100 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 973 | 0.100 |
Why?
|
| Ganglia | 1 | 2010 | 20 | 0.100 |
Why?
|
| In Situ Hybridization | 1 | 2013 | 1037 | 0.100 |
Why?
|
| beta Catenin | 1 | 2015 | 688 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 1217 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 3 | 2007 | 1547 | 0.100 |
Why?
|
| Prostate-Specific Antigen | 1 | 2014 | 993 | 0.100 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2015 | 591 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2014 | 1038 | 0.090 |
Why?
|
| Nitriles | 1 | 2014 | 906 | 0.090 |
Why?
|
| Wound Healing | 1 | 2014 | 815 | 0.090 |
Why?
|
| Disease Progression | 2 | 2013 | 6682 | 0.090 |
Why?
|
| Benzamides | 1 | 2014 | 1832 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2014 | 3536 | 0.080 |
Why?
|
| Carcinogenesis | 1 | 2015 | 1026 | 0.080 |
Why?
|
| 3T3 Cells | 2 | 2005 | 355 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 3639 | 0.080 |
Why?
|
| Macrophages | 1 | 2014 | 1304 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2021 | 3341 | 0.080 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 221 | 0.070 |
Why?
|
| Protein Biosynthesis | 2 | 2003 | 889 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2014 | 6150 | 0.070 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2005 | 45 | 0.070 |
Why?
|
| Liver | 1 | 2015 | 2961 | 0.060 |
Why?
|
| Apoptosis | 2 | 2017 | 7591 | 0.060 |
Why?
|
| Female | 3 | 2022 | 141928 | 0.060 |
Why?
|
| Antigen-Antibody Complex | 1 | 2003 | 115 | 0.060 |
Why?
|
| Muramidase | 1 | 2003 | 110 | 0.060 |
Why?
|
| TNF Receptor-Associated Factor 4 | 1 | 2023 | 23 | 0.060 |
Why?
|
| HIV-1 | 1 | 2007 | 653 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2007 | 1033 | 0.050 |
Why?
|
| Aging | 1 | 2010 | 1582 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2014 | 7226 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2013 | 9180 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2001 | 227 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2001 | 208 | 0.050 |
Why?
|
| Protein Structure, Secondary | 1 | 2001 | 336 | 0.050 |
Why?
|
| Binding Sites | 2 | 2003 | 2171 | 0.050 |
Why?
|
| Ubiquitination | 1 | 2023 | 575 | 0.050 |
Why?
|
| Radioimmunotherapy | 1 | 2021 | 119 | 0.050 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 2864 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2003 | 1732 | 0.050 |
Why?
|
| Macrophage Activation | 1 | 2020 | 148 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2021 | 263 | 0.040 |
Why?
|
| Ligands | 1 | 2001 | 995 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 3203 | 0.040 |
Why?
|
| Coleoptera | 1 | 1997 | 19 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 1487 | 0.040 |
Why?
|
| Vitamin D | 1 | 2020 | 261 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1997 | 611 | 0.040 |
Why?
|
| Protein Stability | 1 | 2017 | 370 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 1997 | 644 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2017 | 591 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 1213 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2017 | 886 | 0.030 |
Why?
|
| Protein Binding | 1 | 2001 | 3438 | 0.030 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2014 | 72 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 11538 | 0.030 |
Why?
|
| Osteopontin | 1 | 2014 | 148 | 0.030 |
Why?
|
| Fibronectins | 1 | 2014 | 197 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2014 | 360 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2014 | 626 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 7548 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 2015 | 382 | 0.030 |
Why?
|
| Cell Movement | 2 | 2014 | 2466 | 0.030 |
Why?
|
| Organoids | 1 | 2014 | 287 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 2927 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2014 | 1008 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2014 | 668 | 0.030 |
Why?
|
| Escherichia coli | 1 | 1997 | 1203 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 943 | 0.020 |
Why?
|
| Cell Division | 1 | 2014 | 2489 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2003 | 4367 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 6295 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1997 | 3154 | 0.020 |
Why?
|
| Genetic Variation | 1 | 1997 | 2086 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 2216 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 1399 | 0.020 |
Why?
|
| Time Factors | 1 | 2001 | 12926 | 0.020 |
Why?
|
| Obesity | 1 | 2020 | 2884 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2007 | 837 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2007 | 582 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 4917 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2014 | 4078 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 2003 | 126 | 0.010 |
Why?
|
| CHO Cells | 1 | 2003 | 311 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 377 | 0.010 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2003 | 109 | 0.010 |
Why?
|
| Chickens | 1 | 2003 | 523 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 3230 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 5159 | 0.010 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2003 | 173 | 0.010 |
Why?
|
| Cricetinae | 1 | 2003 | 706 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 2003 | 266 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 3552 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 2027 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2003 | 330 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2003 | 627 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2003 | 1519 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 32848 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 5637 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 4557 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 7789 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 6089 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 21445 | 0.010 |
Why?
|
| Mutation | 1 | 2015 | 15179 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 77950 | 0.000 |
Why?
|